Shown verbatim: the complete text as captured from the official PDF posted by the Delaware General Assembly, fetched 2026-09-25. Page and line markers are part of the official record; nothing is edited or removed. This is the current version. The official bill page.
SPONSOR: Sen. Poore & Sen. Pinkney & Rep. Ortega
Sens. Buckson, Hoffner, Lawson; Reps. Bolden, Morrison
DELAWARE STATE SENATE
153rd GENERAL ASSEMBLY
SENATE BILL NO. 182
AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PHARMACY.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:
1 Amend § 2523, Title 24 of the Delaware Code by making deletions as shown by strike through and insertions as
2 shown by underline as follows:
3 § 2523. Exemptions.
4 Nothing in this chapter may be construed to prevent any of the following:
5 (10) A manufacturer or wholesaler from providing distribution of dialysate drugs or devices necessary to perform
6 home dialysis on patients with end-stage renal disease, provided that all of the following criteria are met:
7 a. The dialysate drugs or devices are approved by the U. S. Food and Drug Administration as required by
8 federal law.
9 b. The dialysate drugs or devices are lawfully held by a manufacturer or a manufacturer’s agent that is
10 properly registered with the Board as a manufacturer or wholesaler.
11 c. The dialysate drugs or devices are held and delivered in their original, sealed label packaging from the
12 manufacturing facility.
13 d. The dialysate drugs or devices are delivered only by the manufacturer or the manufacturer’s agent and
14 only upon receipt of a prescription from a practitioner.
15 e. The manufacturer or the manufacturer’s agent delivers the dialysate drugs or devices directly to one of
16 the following:
17 1. A patient with end stage renal disease or the patient’s designee for the patient’s self-
18 administration of dialysis therapy.
19 2. A health care provider or institution for administration or delivery of the dialysis therapy to a
20 patient with end stage renal disease.
SYNOPSIS
This Act allows drug manufacturers or their agents and wholesalers to ship dialysate drugs and devices directly to
home dialysis patients without a pharmacy license.
Author: Senator Poore
SD : AVP : CBK Page 1 of 1 Released: 06/10/2025 05:28 PM
4761530114Every fact on this page links to its source, starting with the official bill record.